Role of P2X7 receptor in osteogenic differentiation of periodontal ligament stem cells

doi:10.3969/j.issn.2095-4344.2015.06.008

Abstract

Abstract:

BACKGROUND: Ion channels related to the osteogenic differentiation of periodontal ligament stem cells have been studied.
OBJECTIVE: To preliminarily investigate the effect of P2X7 receptor on the osteogenic differentiation of human periodontal ligament stem cells.
METHODS: Human periodontal ligament stem cells were isolated and divided into four groups, cultured in
100 nmol/L adenosine triphosphate+osteogenic medium, osteogenic medium, 100 nmol/L adenosine triphosphate, and normal culture medium (control group), respectively. After induction for 7 and 14 days, osteogenic effect was detected by alizarin red staining, and expressions of OCN, Runx2 and P2X7 receptor at mRNA and protein levels were analyzed by qRT-PCR and western blot assay, respectively.
RESULTS AND CONCLUSION: Under alizarin red staining, the osteogenic effect of periodontal ligament stem
cells was better in the group of adenosine triphosphate+osteogenic medium than the osteogenic medium group at 7 days, but it was better in the osteogenic medium group than the group of adenosine triphosphate+osteogenic medium at 14 days (P < 0.05). Results from qRT-PCR showed that, in the group of adenosine triphosphate+osteogenic medium, the mRNA expression of Runx2 and OCN reached peak at 7 days, but decreased significantly at 14 days (P < 0.05). The expression of P2X7 receptor mRNA in the group of adenosine triphosphate+osteogenic medium was significantly higher than that in the adenosine triphosphate group at 7 days (P < 0.05), but significantly lower than that in the adenosine triphosphate group at 14 days (P < 0.05). There was no expression of P2X7 receptor mRNA in the osteogenic medium group and control group. Western blot assay showed that at 7 days, the expression of P2X7 receptor peaked in the adenosine triphosphate+osteogenic medium group at 7 days, which was significantly higher than that in the adenosine triphosphate group, and there was a low expression of P2X7 receptor in the osteogenic medium group and no expression in the control group; at 14 days, the expression of P2X7 receptor decreased significantly in the adenosine triphosphate+osteogenic medium group but increased in the adenosine triphosphate group. Experimental findings show that exogenous adenosine triphosphate could significantly improve the osteogenic differentiation of periodontal ligament stem cells at 7 days, but after that, inhibit the osteogenic differentiation; exogenous adenosine triphosphate could activate the expression of P2X7 receptor in periodontal ligament stem cells, and P2X7 receptor expression has positive correlation with the osteogenic differentiation of periodontal ligament stem cells.

中国组织工程研究杂志出版内容重点：干细胞；骨髓干细胞；造血干细胞；脂肪干细胞；肿瘤干细胞；胚胎干细胞；脐带脐血干细胞；干细胞诱导；干细胞分化；组织工程

全文链接：

Key words: Stem Cells, Periodontal Ligament, Receptors, Purinergic P2X7, Adenosine Triphosphate

CLC Number:

R394.2

Sun Ya-nan, Wei Jian-min, Sun Wei, Wu Jun-jie, Wu Li-an. Role of P2X7 receptor in osteogenic differentiation of periodontal ligament stem cells[J]. Chinese Journal of Tissue Engineering Research, 2015, 19(6): 861-867.

Figures/Tables 2

References

[1] Aimetti M. Nonsurgical periodontal treatment. Int J Esthet Dent. 2014;9(2):251-267.
[2] Mathur S, Chopra R, Pandit IK, et al. Stem cell research: applicability in dentistry. Int J Oral Maxillofac Implants. 2014; 29(2):e210-219.
[3] Estrela C, Alencar AH, Kitten GT, et al. Mesenchymal stem cells in the dental tissues: perspectives for tissue regeneration. Braz Dent J. 2011;22(2):91-98.
[4] Bowler WB, Birch MA, Gallagher JA, et al. Identification and cloning of human P2U purinoceptor present in osteoclastoma, bone, and osteoblasts.J Bone Miner Res. 1995;10(7):1137- 1145.
[5] Bowler WB, Littlewood-Evans A, Bilbe G, et al. P2Y2 receptors are expressed by human osteoclasts of giant cell tumor but do not mediate ATP-induced bone resorption. Bone. 1998;22(3):195-200.
[6] Reimer WJ, Dixon SJ. Extracellular nucleotides elevate [Ca2+]i in rat osteoblastic cells by interaction with two receptor subtypes. Am J Physiol. 1992;263(5 Pt 1): C1040-1048.
[7] Morrison MS, Turin L, King BF, et al. ATP is a potent stimulator of the activation and formation of rodent osteoclasts. J Physiol. 1998;511(Pt 2):495-500.
[8] Yu H, Ferrier J. Osteoblast-like cells have a variable mixed population of purino/nucleotide receptors. FEBS Lett. 1993; 328(1-2):209-214.
[9] Gartland A, Hipskind RA, Gallagher JA, et al. Expression of a P2X7 receptor by a subpopulation of human osteoblasts. J Bone Miner Res. 2001;16(5):846-856.
[10] Baron L, Gombault A, Fanny M, et al.The NLRP3 inflammasome is activated by nanoparticles through ATP, ADP and adenosine.Cell Death Dis. 2015;6:e1629.
[11] Ousingsawat J, Wanitchakool P, Kmit A, et al. Anoctamin 6 mediates effects essential for innate immunity downstream of P2X7 receptors in macrophages.Nat Commun. 2015;6:6245.
[12] Amoroso F, Capece M, Rotondo A, et al. The P2X7 receptor is a key modulator of the PI3K/GSK3β/VEGF signaling network: evidence in experimental neuroblastoma.Oncogene. 2015 Jan 26. doi: 10.1038/onc.2014.444. [Epub ahead of print]
[13] 杜侠莹,周新妹,万晓,等.中枢神经系统P2X7受体的结构与功能[J].医学综述,2012,18(3):330-332.
[14] Fountain SJ. Primitive ATP-activated P2X receptors: discovery, function and pharmacology. Front Cell Neurosci. 2013;7:247.
[15] Manaka S, Tanabe N, Kariya T, et al. Low-intensity pulsed ultrasound-induced ATP increases bone formation via the P2X7 receptor in osteoblast-like MC3T3-E1 cells. FEBS Lett. 2015;589(3):310-318.
[16] Glaser T, de Oliveira SL, Cheffer A, et al. Modulation of mouse embryonic stem cell proliferation and neural differentiation by the P2X7 receptor. PLoS One. 2014; 9(5): e96281.
[17] Rodrigues-Ribeiro R, Alvarenga ÉC, Calio ML, et al. Dual Role of P2 Receptors during Osteoblast Differentiation.Cell Biochem Biophys. 2015;71(2):1225-1233.
[18] 王阿娴,唐丽,梁源,等.人骨髓来源细胞外基质对人牙周膜干细胞增殖的影响[J]. 中国组织工程研究, 2014,18(6): 938-943.
[19] Di Virgilio F, Chiozzi P, Ferrari D, et al. Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood. 2001;97(3):587-600.
[20] Duan S, Neary JT. P2X(7) receptors: properties and relevance to CNS function. Glia. 2006;54(7):738-746.
[21] Ryu JK, Jantaratnotai N, Serrano-Perez MC, et al. Block of purinergic P2X7R inhibits tumor growth in a C6 glioma brain tumor animal model. J Neuropathol Exp Neurol. 2011;70(1): 13-22.
[22] White N, Burnstock G. P2 receptors and cancer. Trends Pharmacol Sci. 2006;27(4):211-217.
[23] Solini A, Cuccato S, Ferrari D, et al. Increased P2X7 receptor expression and function in thyroid papillary cancer: a new potential marker of the disease. Endocrinology. 2008;149(1): 389-396.
[24] Adinolfi E, Melchiorri L, Falzoni S, et al. P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia. Blood. 2002;99(2):706-708.
[25] Takenouchi T, Sekiyama K, Sekigawa A, et al. P2X7 receptor signaling pathway as a therapeutic target for neurodegenerative diseases. Arch Immunol Ther Exp (Warsz). 2010;58(2):91-96.
[26] Bernardino L, Balosso S, Ravizza T, et al. Inflammatory events in hippocampal slice cultures prime neuronal susceptibility to excitotoxic injury: a crucial role of P2X7 receptor-mediated IL-1beta release. J Neurochem. 2008; 106(1):271-280.
[27] Matute C, Torre I, Pérez-Cerdá F, et al. P2X(7) receptor blockade prevents ATP excitotoxicity in oligodendrocytes and ameliorates experimental autoimmune encephalomyelitis. J Neurosci. 2007;27(35):9525-9533.
[28] Yang Z, Levison SW. Hypoxia/ischemia expands the regenerative capacity of progenitors in the perinatal subventricular zone. Neuroscience. 2006;139(2):555-564.
[29] Ng SY, Chin CH, Lau YT, et al. Role of voltage-gated potassium channels in the fate determination of embryonic stem cells. J Cell Physiol. 2010;224(1):165-177.
[30] Orriss IR, Key ML, Brandao-Burch A,et al.The regulation of osteoblast function and bone mineralisation by extracellular nucleotides: The role of p2x receptors.Bone. 2012;51(3): 389-400.
[31] Orriss IR, Knight GE, Ranasinghe S, et al. Osteoblast responses to nucleotides increase during differentiation. Bone. 2006;39(2):300-309.
[32] Hoebertz A, Mahendran S, Burnstock G, et al. ATP and UTP at low concentrations strongly inhibit bone formation by osteoblasts: a novel role for the P2Y2 receptor in bone remodeling. J Cell Biochem. 2002;86(3):413-419.
[33] Korcok J, Raimundo LN, Ke HZ, et al. Extracellular nucleotides act through P2X7 receptors to activate NF-kappaB in osteoclasts. J Bone Miner Res. 2004;19(4): 642-651.